AcelRx Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Talphera

11/08/2022 22:02

* AcelRx Pharmaceuticals Inc  ACRX.OQ  reported a quarterly
adjusted loss of 6 cents​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of 7 cents per share.
    * Revenue rose 28.7% to $570.00 thousand from a year ago;
analysts
expected $550.00 thousand. 
    * AcelRx Pharmaceuticals Inc's reported EPS for the quarter
was 48
cents​.
    * The mean earnings estimate of analysts had fallen by
about 25%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * AcelRx Pharmaceuticals Inc shares had fallen by 3.8% this
quarter and lost 58.1% so far this year.
    * The company reported quarterly net income of $70.66
million.
    * Wall Street's median 12-month price target for AcelRx
Pharmaceuticals Inc is $4.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 09:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.07          -0.06          Beat
 Mar. 31 2022      -0.06          -0.06          Met
 Dec. 31 2021      -0.07          -0.06          Beat
 Sep. 30 2021      -0.07          -0.07          Met